Usefulness of 11C Methionine PET in patients with epilepsy or brain tumor

Usefulness of 11C Methionine PET in patients with epilepsy or brain tumor - 11C Methionine PET in epilepsy or brain tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010857

Enrollment

Registered

2013-06-20

Start date

2012-12-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy, brain tumor

Interventions

11C methionine PET

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with epilepsy Patients with brain tumor

Exclusion criteria

Exclusion criteria: 1. Persons with severe physical conditions 2. Expecting mother at PET examination 3. Persons with contraindications of MRI or PET 4. Inadequate persons decided by medical doctors

Design outcomes

Primary

Measure	Time frame
Pathological findings	—

Secondary

Measure	Time frame
Sensitivity of 11C methionine PET	—

Countries

Japan

Contacts

Public ContactHiroshi Matsuda

National Center of Neurology and Psychiatry Integrative Brain Imaging Center

matsudah@ncnp.go.jp042-341-2094

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026